Previous close | 25.20 |
Open | 25.40 |
Bid | 25.40 x N/A |
Ask | 26.00 x N/A |
Day's range | 25.40 - 25.40 |
52-week range | 22.00 - 32.60 |
Volume | |
Avg. volume | 5 |
Market cap | 7.072B |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | 46.18 |
EPS (TTM) | 0.55 |
Earnings date | N/A |
Forward dividend & yield | 0.05 (0.21%) |
Ex-dividend date | 07 June 2023 |
1y target est | N/A |
PIOMBINO DESE, Italy, April 25, 2024--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first quarter of 2024 on Thursday, May 9, 2024, at 6:30 a.m. (ET).
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In this piece, we will take a look at the 11 best Italian stocks to invest in 2024. If you want to skip our overview of the Italian economy and all the latest news, then you can take a look at the 5 Best Italian Stocks To Invest In 2024. The global economy, and particularly […]